Chris Watson,John Baugh,Mark Ledwidge,Ken McDonald
申请号:
US14893920
公开号:
US20160106771A1
申请日:
2014.05.26
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present invention relates to therapies and therapeutic agents for use in the treatment of cardiomyopathies. In particular, the invention is concerned with, but not limited to therapies and therapeutic agents for use in the treatment of hypertrophic cardiomyopathy. Such therapeutic agents comprise hypomethylating agents.